Fujian Cancer Hospital

This study is for people with advanced nasopharyngeal cancer. It aims to find the best day to add an immunotherapy drug (toripalimab) to standard chemotherapy before radiation. Researchers will compare giving the drug on Day 1, Day 5, or Day 9 of the chemo cycle to see which timi…

This study is testing a new combination treatment for people whose nasopharyngeal cancer has returned in the original area after initial treatment. It will enroll 25 patients to receive an initial phase of two drugs (MRG003 and Tislelizumab) followed by a year of maintenance ther…

This study is testing a new combination of three cancer drugs (sintilimab, nimotuzumab, and chemotherapy) followed by radiation for people with advanced head and neck cancer that has not spread to distant parts of the body. The main goal is to see if this approach can effectively…

This study is testing a drug called Ivarmacitinib for people with advanced solid tumors who had to stop a promising type of cancer treatment (immunotherapy) because of severe side effects. The goal is to see if Ivarmacitinib can help control these side effects so that patients mi…

This study is testing if taking a specific probiotic (Lactobacillus reuteri) before surgery, along with standard immunotherapy, helps patients with liver cancer. It aims to see if this combination helps the liver recover better after surgery and improves long-term survival. Resea…

This study aims to find out which treatment approach works better for patients with advanced nasopharyngeal cancer when their initial chemotherapy doesn't shrink the tumor enough. Researchers will observe 223 patients who receive either additional chemotherapy followed by radiati…

This study is testing if adding an immunotherapy drug (serplulimab) to standard chemotherapy before surgery can help people with a rare and aggressive type of esophageal cancer called small cell carcinoma. The goal is to see if this combination can shrink or even eliminate the tu…

This study is testing a more personalized approach to radiation therapy for nasopharyngeal cancer, which starts in the upper throat. For patients with certain low-risk features, doctors want to see if they can safely skip radiation to one specific area of the neck (called Level V…

This study is testing a three-part treatment for advanced kidney cancer that has spread. It combines a precise, high-dose radiation treatment (SBRT) with two drugs: one that blocks tumor blood supply and one that boosts the immune system. The goal is to see how well this combinat…

This study is testing whether a drug called hetrombopag can prevent a serious side effect of chemotherapy for nasopharyngeal (nose and throat) cancer. The side effect, called thrombocytopenia, is when platelet counts drop too low, raising the risk of dangerous bleeding. The study…

This study is testing whether a drug called hetrombopag can prevent or reduce severe drops in platelet counts (thrombocytopenia) caused by certain breast cancer treatments known as ADC drugs. It will enroll 72 breast cancer patients who are either starting ADC treatment or who pr…

This study is testing whether a cream called triethanolamine can prevent or reduce vaginal inflammation (radiation vaginitis) caused by radiotherapy for cervical cancer. Researchers will compare the cream plus standard care against standard care alone in about 238 patients. The m…